Dallas, TX 的 心房顫動 臨床試驗
9 項針對 心房顫動 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
招募中3 期
- University of Texas Southwestern Medical Center, Dallas
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
招募中觀察性研究
- Baylor Scott & White Research Institute, Dallas
- Medical City Dallas Hospital, Dallas
The Fourth Left Atrial Appendage Occlusion Study
招募中
- Baylor Research Institute, Dallas
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
招募中3 期
- Southwest Family Medicine Associates, Dallas
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
招募中
- Texas Cardiac Arrhythmia Research Foundation, Dallas
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
招募中3 期
- Anthos Investigative Site 9943, Dallas
- Anthos Investigative Site 9942, Dallas
BoxX-NoAF Clinical Trial
招募中歡迎健康志工
- Baylor Research Institute - Baylor Scott and White Research Institute, Dallas
Get With the Guidelines Atrial Fibrillation Registry
招募中觀察性研究歡迎健康志工
- Amy Bennett, Dallas
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
招募中觀察性研究
- UT Southwestern Medical Center, Dallas
其他城市的 心房顫動 試驗
- New York City, NY21 項研究
- Cleveland, OH17 項研究
- Boston, MA17 項研究
- Atlanta, GA16 項研究
- Jonesboro, AR12 項研究
- Chicago, IL12 項研究
- Philadelphia, PA12 項研究
- Ann Arbor, MI11 項研究
- Columbus, OH10 項研究
- Cincinnati, OH10 項研究
- Pittsburgh, PA10 項研究
- Orlando, FL9 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。